Avanir Pharmaceuticals – Trademark Portfolio

Entity Type: 03

Avanir Pharmaceuticals holds 20 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 20 filings in this category. Currently, 2 trademarks are registered. Notable registered marks include ABREVA and NUEDEXTA. The owner is based in Aliso Viejo, CA.

Suite 300

101 Enterprise

Aliso Viejo, CA 92656

20 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

KOZANT
KOZANT
Abandoned 2009
ZENVIA
ZENVIA
Abandoned 2007
LEVIUM
LEVIUM
Abandoned 2007
NEURODEX
NEURODEX
Abandoned 2006
NEUVAR
NEUVAR
Abandoned 2006
NUEDEXTA
NUEDEXTA
Registered 2006
KOZANT
KOZANT
Abandoned 2006
AVENIUM
AVENIUM
Abandoned 2004
CEREVID
CEREVID
Abandoned 2004
ALIBRE
ALIBRE
Abandoned 2003
VIAZEN
VIAZEN
Abandoned 2003
LEVIUM
LEVIUM
Abandoned 2003
ZENVIA
ZENVIA
Abandoned 2003
AVANIR
AVANIR
Cancelled 1999
ABREE
ABREE
Abandoned 1998
ABREVA
ABREVA
Registered 1998
ABREVE.
ABREVE.
Abandoned 1998
ABREVE
ABREVE
Abandoned 1998
TRILIAM
TRILIAM
Abandoned 1998

Trademark Classifications

Avanir Pharmaceuticals's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (20 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Avanir Pharmaceuticals have?

Avanir Pharmaceuticals has 20 U.S. trademarks filed with the USPTO. Of these, 2 registered, 17 abandoned, 1 cancelled.

What trademark classes does Avanir Pharmaceuticals file in?

Avanir Pharmaceuticals files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Avanir Pharmaceuticals's most well-known trademarks?

Avanir Pharmaceuticals's registered trademark portfolio includes well-known marks such as ABREVA and NUEDEXTA. These are among 2 currently registered trademarks in the portfolio.

What is Avanir Pharmaceuticals's trademark registration success rate?

Avanir Pharmaceuticals has a 10% trademark registration rate, with 2 out of 20 resolved applications resulting in successful registration. Currently, 0 applications are pending review.